Asset
ACP-001
Ascendis Pharma A/S Ordinary Share
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01247675 | phase2 | completed | 2010-11-01 | 2011-05-01 | Ascendis Pharma A/S | A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency |
| NCT01010425 | phase1 | completed | 2009-11-01 | 2010-02-01 | Ascendis Pharma A/S | Pharmacokinetics and Pharmacodynamics of ACP-001 (TransCon PEG hGH) |
| NCT01947907 | phase2 | completed | 2013-07-01 | 2015-07-01 | Ascendis Pharma A/S | Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) |
FDA applications (0)
This company has no applications containing this asset.